4-Hydroxy-10-methyl-4-oxo-3,5,13-trioxa-10-aza-4lambda5-phosphatetracyclo[5.5.1.02,6.08,12]tridecane-9,11-dione

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 4-Hydroxy-10-methyl-4-oxo-3,5,13-trioxa-10-aza-4lambda5-phosphatetracyclo[5.5.1.02,6.08,12]tridecane-9,11-dione
• 英文别名: 4-hydroxy-10-methyl-4-oxo-3,5,13-trioxa-10-aza-4λ5-phosphatetracyclo[5.5.1.02,6.08,12]tridecane-9,11-dione
• 化学式: C₉H₁₀NO₇P
• 分子量: 275.15
• InChiKey: XKYYYHDEBATQGH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.6
• 重原子数：
  18
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  102
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• US20140256911A1
  申请人：——

  公开号：US20140256911A1

  公开（公告）日：2014-09-11
• Preparation of Oligo Conjugates
  申请人：Emerald Therapeutics, Inc.

  公开号：US20160333045A1

  公开（公告）日：2016-11-17

  Conjugated molecules are prepared that comprise a predetermined number of oligo conjugation components. The conjugated molecules also may comprise one or more detectable labels. Preparation of these molecules can be implemented according to an asymmetric or a symmetric conjugation strategy.
• PREPARATION OF OLIGO CONJUGATES
  申请人：Emerald Therapeutics, Inc.

  公开号：US20220009956A1

  公开（公告）日：2022-01-13

  Conjugated molecules are prepared that comprise a predetermined number of oligo conjugation components. The conjugated molecules also may comprise one or more detectable labels. Preparation of these molecules can be implemented according to an asymmetric or a symmetric conjugation strategy.
• US9289502B2
  申请人：——

  公开号：US9289502B2

  公开（公告）日：2016-03-22